Dyadic International Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.85

+0.00 (+0.26%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,732.3% upside

Low Target $20.70

Average Target $32.64

High Target $34.69

Current Price $0.85

Current
$0.85

Target
$32.64

$20.70 $32.64 avg $34.69

Scenario Analysis

Bear Case

$20.70

2,330.4%

Low target

Base Case

$32.64

+3,732.3%

Avg target

Bull Case

$34.69

+3,973.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$36.35

-97.7% from high

52-Week Low

$13.94

+-93.9% from low

Target vs 52W High

$32.64

-10.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%